spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Shionogi 

 HSMN NewsFeed - 22 Jun 2021
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE(R) drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 5 Dec 2018
Vast Therapeutics Announces Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 22 Nov 2013
Tivicay(R) (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV
Biopharmaceuticals HIV/AIDS Regulatory
 HSMN NewsFeed - 8 Nov 2012
Genoa Pharmaceuticals announces $1.2M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Mar 2012
InterMune Appoints Mr. Jean-Jacques Bienaime and Dr. Frank Verwiel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2011
Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2011
InterMune Announces Launch of Esbriet(R) (pirfenidone) in Germany
Biopharmaceuticals
 HSMN NewsFeed - 2 May 2011
ARMGO Pharma Inc., Announces the Appointment of Dr. Sapan Shah as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2011
Shionogi Announces New US Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2011
InterMune Receives European Union Approval for Esbriet(R) (pirfenidone)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Jan 2011
Mylan Receives Approval for First-to-File Generic Sular(R) Extended-Release Tablets
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 4 Jan 2011
Response Biomedical Corporation Enters Into Exclusive Italian Distribution Agreement with Cremascoli & Iris, s.r.l.
Diagnostics Distribution
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Jul 2010
Shionogi Inc. Announces FDA Approval of CUVPOSA for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jul 2010
Shionogi Announces Reorganization of US Operations, New Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Feb 2010
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 21 Jan 2010
Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2010
BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2009
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 29 Jul 2009
Sciele Pharma and Plethora Solutions Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2009
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2009
Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2009
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 19 Sep 2008
Shionogi and Sciele Announce Receipt of United States Antitrust Clearance
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2008
Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Aug 2008
Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
Biopharmaceuticals
 HSMN NewsFeed - 13 Aug 2008
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 30 Jun 2008
Tobira Therapeutics Inc. Announces Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jun 2008
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Apr 2008
InterMune Announces Progress on Pirfenidone in IPF
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2008
Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 Jan 2008
Anthera Pharmaceuticals Acquires the Worldwide Rights to a BAFF Inhibitor for the Treatment of Lupus and Other Autoimmune Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Dec 2007
BioCryst Provides Forodesine HCl Update
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Nov 2007
InterMune Buys Out License Agreement for Pirfenidone
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Nov 2007
CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
Biopharmaceuticals FDA Cardiology
 HSMN NewsFeed - 7 Nov 2007
New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Nov 2007
New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Oct 2007
FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 12 Oct 2007
BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Sep 2007
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2007
Response Biomedical appoints S. Wayne Kay Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 31 Aug 2007
Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Biopharmaceuticals
 HSMN NewsFeed - 8 Aug 2007
BioCryst Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2007
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2007
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
Biopharmaceuticals
 HSMN NewsFeed - 19 Apr 2007
AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH
Biopharmacetuicals Urology
 HSMN NewsFeed - 2 Apr 2007
BioCryst Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2007
BioCryst Provides Fodosine(TM) Update
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2007
InterMune Updates Expense Forecasts and Development Plans
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2007
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
AEterna Zentaris Initiates First Study of Phase 3 Program with Cetrorelix in BPH - 600 Patient Trial Conducted in the United States and Canada
Biopharmaceuticals Urology
 HSMN NewsFeed - 13 Sep 2006
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Sep 2006
Anthera Licenses Portfolio of Anti-Inflammatory Products From Eli Lilly and Company and Shionogi & Co., Ltd.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Aug 2006
Response Biomedical Initiates US Clinical Trials of RAMP NT-proBNP Test for the Diagnosis of Congestive Heart Failure
Diagnostics Cardiology
 HSMN NewsFeed - 5 Jul 2006
Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Jun 2006
New Data Shows CRESTOR(R) Helped African American, Hispanic American and South Asian American Patients Significantly Lower LDL-C and Achieve Cholesterol Goals
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Jun 2006
AEterna Zentaris Receives Green Light from FDA to Move Forward into Phase 3 Program with Cetrorelix in BPH
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 17 May 2006
MorphoSys and Schering-Plough Sign R&D Agreement
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2006
CRESTOR Helped More Patients Reach Goal in MERCURY II Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 May 2006
Response Biomedical and Shionogi Finalize Commercialization Agreement For RAMP Cardiovascular Testing in Japan
Diagnostics Cardiology
 HSMN NewsFeed - 27 Apr 2006
InterMune Initiates Phase III Program Evaluating Pirfenidone in Patients With IPF
Biopharmaceuticals
 HSMN NewsFeed - 20 Apr 2006
AEterna Zentaris Gains Market Approval for Cetrotide(R) (cetrorelix) in Japan for In Vitro Fertilization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Mar 2006
First-Ever Large-Scale Prospective Study in Hispanic Patients With Elevated Cholesterol Demonstrates Significant Cholesterol Reductions With CRESTOR(R)
Biopharmaceuticals
 HSMN NewsFeed - 30 Jan 2006
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights for Cetrorelix in Benign Prostate Hyperplasia
Biopharmaceuticals Urology
Return to NewsFeed  

 Additional items found! 31

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 31 additional stories matching:
Shionogi
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.